These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 1906498)

  • 1. Fluoxetine, fluvoxamine and extrapyramidal tract disorders.
    Baldwin D; Fineberg N; Montgomery S
    Int Clin Psychopharmacol; 1991; 6(1):51-8. PubMed ID: 1906498
    [No Abstract]   [Full Text] [Related]  

  • 2. 5-HT reuptake inhibitors in healthy human subjects.
    Netter P
    Clin Neuropharmacol; 1986; 9 Suppl 4():162-4. PubMed ID: 3105878
    [No Abstract]   [Full Text] [Related]  

  • 3. Apathy and indifference in patients on fluvoxamine and fluoxetine.
    Hoehn-Saric R; Lipsey JR; McLeod DR
    J Clin Psychopharmacol; 1990 Oct; 10(5):343-5. PubMed ID: 2124218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent studies on selective serotonergic antidepressants: trazodone, fluoxetine, and fluvoxamine.
    Schatzberg AF; Dessain E; O'Neil P; Katz DL; Cole JO
    J Clin Psychopharmacol; 1987 Dec; 7(6 Suppl):44S-49S. PubMed ID: 3123528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A controlled trial of fluvoxamine in obsessive-compulsive disorder: implications for a serotonergic theory.
    Jenike MA; Hyman S; Baer L; Holland A; Minichiello WE; Buttolph L; Summergrad P; Seymour R; Ricciardi J
    Am J Psychiatry; 1990 Sep; 147(9):1209-15. PubMed ID: 2143637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fenfluramine augmentation of serotonin reuptake blockade antiobsessional treatment.
    Hollander E; DeCaria CM; Schneier FR; Schneier HA; Liebowitz MR; Klein DF
    J Clin Psychiatry; 1990 Mar; 51(3):119-23. PubMed ID: 2106515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of hypokinetic rigid syndrome with fluvoxamine maleate.
    Meerwaldt JD
    Lancet; 1986 Apr; 1(8487):977-8. PubMed ID: 2871275
    [No Abstract]   [Full Text] [Related]  

  • 8. Fluvoxamine: an antidepressant with low (or no) epileptogenic effect.
    Harmant J; van Rijckevorsel-Harmant K; de Barsy T; Hendrickx B
    Lancet; 1990 Aug; 336(8711):386. PubMed ID: 1975375
    [No Abstract]   [Full Text] [Related]  

  • 9. Akathisia, suicidality, and fluoxetine.
    Hamilton MS; Opler LA
    J Clin Psychiatry; 1992 Nov; 53(11):401-6. PubMed ID: 1364815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of depersonalization with serotonin reuptake blockers.
    Hollander E; Liebowitz MR; DeCaria C; Fairbanks J; Fallon B; Klein DF
    J Clin Psychopharmacol; 1990 Jun; 10(3):200-3. PubMed ID: 2115893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical experience with serotonin reuptake inhibiting antidepressants.
    Mendels J
    J Clin Psychiatry; 1987 Mar; 48 Suppl():26-30. PubMed ID: 2950077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serotonin syndrome produced by a combination of fluoxetine and lithium.
    Muly EC; McDonald W; Steffens D; Book S
    Am J Psychiatry; 1993 Oct; 150(10):1565. PubMed ID: 8379573
    [No Abstract]   [Full Text] [Related]  

  • 13. Fluoxetine associated with severe extrapyramidal symptoms in a patient with basal ganglia lesion.
    Caixeta L
    Braz J Psychiatry; 2009 Jun; 31(2):182-3. PubMed ID: 19578693
    [No Abstract]   [Full Text] [Related]  

  • 14. Obsessive-compulsive disorder.
    March JS; Johnston H; Greist JH
    Am Fam Physician; 1989 May; 39(5):175-82. PubMed ID: 2497627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluoxetine and extrapyramidal side effects.
    Am J Psychiatry; 1989 Oct; 146(10):1352-3. PubMed ID: 2604792
    [No Abstract]   [Full Text] [Related]  

  • 16. Memory improvement in Korsakoff's disease with fluvoxamine.
    McEntee WJ; Mair RG
    Arch Gen Psychiatry; 1990 Oct; 47(10):978-9. PubMed ID: 2121117
    [No Abstract]   [Full Text] [Related]  

  • 17. Pituitary-adrenocortical hyperfunction and intolerance to fluvoxamine, a selective serotonin uptake inhibitor.
    Brown WA; Arato M; Shrivastava R
    Am J Psychiatry; 1986 Jan; 143(1):88-90. PubMed ID: 3079969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fluvoxamine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in depressive illness.
    Benfield P; Ward A
    Drugs; 1986 Oct; 32(4):313-34. PubMed ID: 3096686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specificity of serotonin reuptake inhibitors in the treatment of obsessive-compulsive disorder. Comparison of fluvoxamine and desipramine.
    Goodman WK; Price LH; Delgado PL; Palumbo J; Krystal JH; Nagy LM; Rasmussen SA; Heninger GR; Charney DS
    Arch Gen Psychiatry; 1990 Jun; 47(6):577-85. PubMed ID: 2112374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of serotonin uptake inhibitors in anxiety disorders; a double-blind comparison of clomipramine and fluvoxamine.
    den Boer JA; Westenberg HG; Kamerbeek WD; Verhoeven WM; Kahn RS
    Int Clin Psychopharmacol; 1987 Jan; 2(1):21-32. PubMed ID: 3117876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.